Depot-specific mRNA expression programs in human adipocytes suggest physiological specialization via distinct developmental programs.
Clemons HJ., Hogan DJ., Brown PO.
Laboratory Study, published in PLoS One (2024) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- PLoS One (2024)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 39401200
- PMCID
- PMC11472956
- DOI
- 10.1371/journal.pone.0311751
- Citations
- 1
Abstract (original English)
ABSTRACT Adipose tissue is distributed in diverse locations throughout the human body. Not much is known about the extent to which anatomically distinct adipose depots are functionally distinct, specialized organs, nor whether depot-specific characteristics result from intrinsic developmental programs, as opposed to reversible physiological responses to differences in tissue microenvironment. We used DNA microarrays to compare mRNA expression patterns of isolated human adipocytes and cultured adipose stem cells, before and after ex vivo adipocyte differentiation, from seven anatomically diverse adipose tissue depots. Adipocytes from different depots displayed distinct gene-expression programs, which were most closely shared with anatomically related depots. These depot-specific differences in gene expression were recapitulated when adipocyte progenitor cells from each site were differentiated ex vivo, suggesting that progenitor cells from specific anatomic sites are deterministically programmed to differentiate into depot-specific adipocytes. mRNAs whose expression differed between anatomically diverse groups of depots (e.g., subcutaneous vs. internal) suggest important functional specializations. Many developmental transcription factors showed striking depot-specific patterns of expression, suggesting that adipocytes in each anatomic depot are programmed during early developme
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.